We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
36 hedge funds and large institutions have $10.4M invested in Axsome Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,800% more call options, than puts
Call options by funds: $38K | Put options by funds: $2K
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
3% more funds holding
Funds holding: 35 → 36 (+1)
6.26% less ownership
Funds ownership: 22.88% → 16.61% (-6.3%)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
68% less capital invested
Capital invested by funds: $32.6M → $10.4M (-$22.2M)
Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
7
Reduced
8
Closed
10
Calls
$38K
Puts
$2K
Net Calls
+$36K
Net Calls Change
-$86K
Top Buyers
| 1 |
SCM
Sio Capital Management
New York
|
+$579K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$243K |
| 3 |
RA
Royce & Associates
New York
|
+$225K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$178K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$132K |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$3.82M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.69M |
| 3 |
Millennium Management
New York
|
-$705K |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$704K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$670K |
